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Abstract 
 
BACKGROUND: There is increasing interest in DNA methylation studies in Alzheimer’s disease 
(AD), but little is still known concerning the relationship between gene-promoter methylation and 
circulating biomarkers of one-carbon metabolism in the patients. 
OBJECTIVE: to detect the connections among circulating folate, homocysteine (hcy) and vitamin 
B12 levels and promoter methylation levels of PSEN1, BACE1, DNMT1, DNMT3A, DNMT3B and 
MTHFR genes in blood DNA. 
METHODS: We applied a data mining system called Auto Contractive Map to an existing 
database of 100 Alzheimer’s disease (AD) and 100 control individuals.  
RESULTS: Low vitamin B12 was linked to the AD condition, to low folates and to high hcy. Low 
PSEN1 methylation was linked to low folate levels as well as to low promoter methylation of 
BACE1 and DNMTs genes. Low hcy was linked to controls, to high folates and vitamin B12, as 
well as to high methylation levels of most of the studied genes. 
CONCLUSIONS: The present pilot study suggests that promoter methylation levels of the studied 
genes are linked to circulating levels of folates, hcy, and vitamin B12. 
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Introduction 
 
     Alzheimer’s disease (AD) individuals are characterized by impaired one-carbon metabolism, 
which is reflected in increased circulating homocysteine (hcy) and reduced levels of serum folates 
and related B-group vitamins [1]. Indeed, high hcy and low folates are regarded as AD risk factors, 
and could contribute to global and gene-specific DNA methylation changes in AD [2,3]. Results 
from either in vitro studies or animal models revealed that folic acid alone or formulations of B-
group vitamins induce changes in the methylation and or expression of genes required for amyloid-
β peptide (Aβ) production, such as PSEN1 and BACE1, or involved in DNA methylation reactions, 
including DNMTs genes [4-7], but data in AD patients are missing. 
      In the present study we applied Artificial Neural Networks (ANNs) to unravel the connections 
between circulating folate, hcy and vitamin B12 and promoter methylation levels of genes required 
for Aβ production (PSEN1 and BACE1) and DNA methylation reactions (DNMT1, DNMT3A, 
DNMT3B, and MTHFR) in blood DNA obtained from 100 late-onset AD (LOAD) patients and 100 
matched controls. Particularly, we used the Auto Contractive Map algorithm (Auto-CM), a special 
kind of ANN able to define the strength of the associations of each variable with all the others and 
to visually show the map of their main connections and the basic semantic of their ensemble [8]. 
Auto-CM has been successfully applied to AD datasets, for example to link serum folate and hcy 
levels to brain atrophy [9], to unravel genetic polymorphisms linked to impaired one-carbon 
metabolism [10], to detect the connections among studied variables in the nun study [8], to 
differentiate among various forms of dementia [10], or to detect the predictors of response to 
cholinesterase inhibitors [12]. 
 
 
 
 
 Materials and Methods 
Study population 
       The analysis was based on 100 LOAD patients and 100 healthy matched controls (Table 1) 
selected from a previously described database [13] for whom all the following information was 
available: plasma hcy and serum folate and vitamin B12 levels; promoter methylation levels of 
PSEN1, BACE1, DNMT1, DNMT3A, DNMT3B and MTHFR genes; age at sampling; gender. All the 
methylation and biochemical analyses (folate, hcy, vitamin B12) were performed simultaneously 
after blood drawings. A trained neurologist from the Department of Neuroscience of the Pisa 
University Hospital visited cases and controls before inclusion in the study. LOAD patients met the 
diagnostic and statistical manual of mental disorders criteria (DSMIV) [14,15]. Healthy volunteer 
subjects were recruited simultaneously with LOAD patients and matched for age, gender, and 
ethnicity (all Italian Caucasians). All the control subjects underwent a rigorous neurological 
examination before inclusion in the study, in order to exclude the presence of cognitive impairment 
or any other kind of neurological disorder. Furthermore, control subjects were also investigated for 
their familial history of neurological disorders, and only individuals with no relatives who 
developed AD or related disorders were included in the study. In addition, individuals taking 
vitamins, drugs, or supplements known or suspected to interfere with one-carbon metabolism and 
DNA methylation reactions were not enrolled [13]. Each subject gave an informed and written 
consent for the inclusion in the study that received approval from the Ethics Committee of the Pisa 
University Hospital (Protocol number 3618/2012). 
 
Epigenetic and biochemical data collection 
      Peripheral blood samples were collected from each subject for the evaluation of folate, hcy and 
vitamin B12 levels. Promoter methylation levels of PSEN1, BACE1, DNMT1, DNMT3A, DNMT3B 
and MTHFR genes were assessed with validated methylation sensitive high resolution melting (MS-
HRM) protocols [13]. All the data had been previously collected as detailed elsewhere [13] and 
were available in the database at the time of ANNs analysis. Table 1 shows the distribution of 
studied variables between LOAD and control subjects. 
 
Semantic connectivity map 
      In order to graphically show the most important connections among variables we used an 
artificial adaptive system called Auto-CM [8], a special kind of ANN that develops weights that are 
proportional to the strength of the associations of all variables each other. The weights are then 
transformed in physical distances so that couples of variables whose connection weights are higher 
become nearer and vice versa. After the training phase, the weights matrix of the Auto-CM 
represents the warped landscape of the dataset. Subsequently, a simple filter to the weights matrix 
of the Auto-CM system was applied to obtain a map of the main connections between the variables 
of the dataset and the basic semantic of their similarities, defined connectivity map as detailed 
elsewhere [8]. Categorical variables were left as such and numerical variables (folates, hcy, vitamin 
B12, and promoter methylation levels of the six genes under investigation) have been transformed 
in input variables constructing for each of them, scaled from 0 to 1, its complement, as detailed 
elsewhere [9,10]. For example	   the variable MTHFR promoter methylation has natural values 
ranging from 5.9% (lowest observed value) to 74.6% (highest value) in our cohort. According to the 
transformation, 5.9 (the lowest value) becomes 0 and 74.6 (the highest value) becomes 1, and vice-
versa. All the other observed MTHFR promoter methylation values are scaled in this new range. 
Doing this pre-processing for all the studied variables allows a graphical visualization of the 
projection of each variable in the map according to its low and high values.  
 
 
 
 
Results 
       
     Figure 1 shows the semantic connectivity map obtained with Auto-CM. Variables showing the 
maximal amount of connections with other variables are called “hubs”. A numerical value is 
applied to each edge of the graph and is proportional to the strength of the connection between two 
variables (s.a. = strength of association, ranges from 0 = not connected to 1 = highly connected). 
Results clearly indicate that LOAD patients and controls are well separated each other. Particularly 
AD patients are highly connected to low vitamin B12 levels (s.a. = 0.96), which in turn are 
connected to low folates (s.a. = 0.99) and high hcy (s.a. = 0.79). On the contrary, controls are highly 
connected to low hcy (s.a. = 0.96), which is in turn connected to high folates (s.a. = 0.75) and high 
vitamin B12 (s.a. = 0.82). Table 1 shows that vitamin B12 levels were significantly reduced in 
LOAD patients with respect to controls; furthermore, linear regression analysis pointed out a 
significant correlation between serum folate and vitamin B12 levels, and an inverse correlation 
between vitamin B12 and hcy levels, suggesting that individuals with lower vitamin B12 levels are 
likely to have relatively low folate and high hcy values (Supplementary Figure 1). 
      Very interestingly low PSEN1 methylation works as hub of the system and is highly connected 
to low methylation levels of all the other investigated genes. Furthermore, low PSEN1 methylation 
is highly connected to low folates (s.a. = 0.99) as well as to low hcy (s.a. = 0.99). Low hcy is 
another hub of the system, directly connected not only to the condition of being a control or to high 
folate and vitamin B12 levels, but also to high methylation levels of most of the studied genes (s.a. 
ranging from 0.53 to 0.96). Gender is not directly linked to gene promoter methylation, whilst 
increasing age (>80 years) is directly connected to low methylation of DNMT1, and younger ages 
are linked to low hcy (Figure 1). 
       
 
 
Discussion 
 
      ANNs represent a valid tool to dissect complex non-linear interactions among high numbers of 
variables, and in the present pilot study we applied Auto-CM to reveal the connections between 
circulating biomarkers of one-carbon metabolism (folate, hcy, and vitamin B12 levels) and 
promoter methylation levels of selected genes in blood DNA of LOAD and control individuals. 
Very interestingly, Auto-CM revealed that low levels of vitamin B12 were directly connected to the 
LOAD condition; furthermore, low vitamin B12 levels were linked to low folates and high hcy. 
Conversely, low hcy connected to high folates and vitamin B12 were directly linked to the control 
condition. Similar findings have been already obtained by Auto-CM in two previous independent 
AD datasets [9,10], and confirm recent meta-analyses of a large amount of literature overall 
suggesting that reduced folates and increased hcy are both AD risk factors [1]. Conventional 
statistical approaches revealed that vitamin B12 levels were significantly reduced in the present 
LOAD cohort with respect to controls (Table 1). Furthermore, linear regression analysis revealed a 
positive correlation between serum vitamin B12 and serum folate levels, and an inverse correlation 
between serum vitamin B12 and plasma hcy levels (Supplementary Figure 1), suggesting that 
LOAD individuals with low vitamin B12 levels are also characterized by relatively low folates and 
high hcy than individuals with higher vitamin B12 levels, as revealed by Auto-CM analysis. ANNs 
pointed out also some connections between the study variables and gender. For example, male 
gender was linked to low vitamin B12 by Auto-CM, and a conventional statistical approach showed 
a trend for higher vitamin B12 in females than in males in our cohort (Supplementary Figure 1).  
      More interestingly, Auto-CM revealed connections between biomarkers of one-carbon 
metabolism and gene-promoter methylation levels of the selected genes. Particularly, present data 
confirm previous in vitro and animal model results suggesting a link between dietary folates and 
related B-group vitamins and the methylation levels of genes required for Aβ production, such as 
PSEN1 and BACE1 [4-7]. PSEN1 codes for the presenilin 1 protein, involved in the γ-secretase 
cleavage of the amyloid-β protein precursor (AβPP), and is mutated in familial early-onset AD 
cases [16]. BACE1 codes for the β-secretase protein that, together with γ-secretase, is involved in 
the amyloidogenic cleavage of AβPP leading to the production Aβ peptides [17]. The reduction of 
folate and vitamin B12 in culture medium of neuroblastoma cell lines was linked to PSEN1 
demethylation, increased levels of presenilin 1 and BACE proteins, and increased production of Aβ 
peptides [4]. Similar results were observed in brain neurons of mice following a combined dietary 
deficiency of folate, vitamin B12 and vitamin B6 [18]. Studies in humans have revealed that both 
genes are hypo-methylated in blood DNA of AD and control individuals [13,19,20], but no 
correlation between gene-promoter methylation and folate or vitamin B12 levels is yet available in 
human AD tissues.  
      The present Auto-CM analysis also linked low hcy levels to high promoter methylation of genes 
required for DNA methylation reactions (DNMT1, DNMT3A, DNMT3B, and MTHFR), whilst low 
folates and advancing age were linked to their low methylation. So that, present results confirm 
previous cell culture studies revealing that folic acid can impact on DNA methylation levels 
through the modulation of proteins required for DNA methylation reactions [5-7]. Particularly, 
DNMT1 is required for the maintenance of DNA methylation patterns during development and cell 
division, whilst DNMT3a and DNMT3b are de novo methyltransferases that establish DNA 
methylation patterns during early development [21]. Studies in mouse neuronal cells have shown 
that folic acid stimulates DNMTs gene and protein expression, and DNMTs activities, but data in 
human LOAD patients are missing [5,6]. The MTHFR gene codes for methylenetetrahydrofolate 
reductase, a key protein for the inter-conversion of folate derivatives required for DNA methylation 
reactions, and MTHFR genetic polymorphisms have been associated to LOAD risk [22]. Previous 
studies in humans showed that the MTHFR promoter shows inter-individual variability in DNA 
methylation patterns that correlate with circulating folate, vitamin B12 and/or hcy levels [13,23]. 
      We are well aware of the limits of the present study as most of the genes that we have 
investigated showed low methylation levels in blood DNA of AD patients in both present and 
previous investigations [13,19,20], so that their clinical significance is still debated [19]. However, 
at best of our knowledge the present is one of the first evidence linking circulating folate, hcy, and 
vitamin B12 levels to DNA methylation in human LOAD subjects. Therefore, present data are 
indicative that conditions of reduced folate and increased hcy levels, such as those often observed in 
AD patients, might contribute to either global or gene-specific methylation changes that have been 
often observed in blood and brains of those subjects [24], suggesting that further studies are 
warranted to clarify the link between one-carbon metabolism and DNA methylation in AD. We also 
acknowledge that the present investigation is based on a cohort of only 100 LOAD cases and 100 
matched controls, so that present data require confirmation in larger cohorts of individuals. In this 
regard, the present must be considered as a pilot study addressing how several variables are linked 
each other in a given dataset. As such, the present ANNs investigation does not infer about study 
power or statistically significant differences between groups, but helps addressing complex and 
often non-linear interactions among variables, suggesting which ones are closer or not to the others. 
In addition ANNs, at variance with the classical statistical tests, can manage complexity even with 
relatively small samples and to the subsequent unbalanced ratio between variables and records. In 
this connection, it is important to note that adaptive learning algorithms of inference, based on the 
principle of a functional estimation like ANNs, can overcome to a certain degree the problem of 
dimensionality [8]. Unfortunately, as recently reviewed by Bennett and coworkers, we are still at 
the beginning of our comprehension of the contribution of epigenetic mechanisms in LOAD 
pathogenesis, most of the available studies are limited to a few dozens or less than 100 cases, and 
correlations between epigenetic changes and environmental/dietary factors are often missing [25]. 
Within this context, we believe that the present observation of a connection between promoter 
methylation levels of a panel of genes and circulating levels of folate, vitamin B12 and hcy, coupled 
with similar evidence coming from previous in vitro or animal investigations [4-7], should stimulate 
novel questions in AD research to be addressed in future studies, including the following: 1) “Are 
the global methylation changes so far observed in DNA from AD brains and peripheral tissues 
related to the nutritional status, and particularly to the bioavailability of methyl donor compounds?” 
2) “Can we counteract age-related changes in global and/or gene-specific methylation by means of 
nutritional interventions?” These points could be rigorously addressed only by planning either 
prospective or retrospective studies aimed at linking both global and gene-specific methylation 
changes in AD tissues with the bioavailability of methyl donor compounds. Those studies could 
also clarify whether AD-related DNA methylation changes can be prevented by dietary 
interventions. 
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Figure 1.  
 
 
 
Legend to Figure 1: 
 
Semantic connectivity map obtained with Auto-Cm system. The numbers on the arches of the 
graph refer to the strength of the association between two adjacent nodes. The value ranges from 0 
(not linked) to 1 (highly linked). 
 
 
 
 
 
 
  
Table 1. Distribution of study variables between cases and controls 
 
Variable 
 
LOAD 
(n = 100) 
 
Controls  
(n = 100) 
 
p-valuea 
 
Gender (M/F) 
 
46/54 
 
46/54 
 
1.00 
 
Age at sampling (years): mean ± SD 
 
77.5 ± 7.5 
 
76.8 ± 8.4 
 
0.53 
 
Homocysteine (µmol/l): mean ± SD 
 
17.4 ± 11.8 
 
14.8 ± 6.3 
 
0.17 
 
Folate (ng/ml): mean ± SD 
 
6.8 ± 4.9 
 
6.9 ± 4.7 
 
0.77 
 
Vitamin B12 (pg/ml): mean ± SD 
 
403 ± 218 
 
472 ± 310 
 
0.04 
 
PSEN1 methylation (%): mean ± SD 
 
0.6 ± 1.2 
 
0.9 ± 1.9 
 
0.18 
 
BACE1 methylation (%): mean ± SD 
 
0.5 ± 0.9 
 
0.8 ± 1.2 
 
0.06 
 
DNMT1 methylation (%): mean ± SD 
 
2.3 ± 2.9 
 
1.9 ± 2.5 
 
0.29 
 
DNMT3A methylation (%): mean ± SD 
 
0.9 ± 2.2 
 
1.2 ± 2.2 
 
0.33 
 
DNMT3B methylation (%): mean ± SD 
 
2.4 ± 4.1 
 
2.7 ± 3.7 
 
0.59 
 
MTHFR methylation (%): mean ± SD 
 
30.8 ± 11.2 
 
30.3 ± 9.9 
 
0.74 
a  p-value was obtained by chi-square analysis or Student’s t test 
 
 
 
 
 
 
 
 
 
Supplementary Material 
 
 
Supplementary Figure 1: Linear regression analysis pointed out a positive correlation between 
vitamin B12 and folate values (r = 0.16; p = 0.019) (A), and an inverse correlation between hcy and 
vitamin B12 values (r = -0.25; p = 0,0004) (B). Vitamin B12 values tended to be higher in females 
than in males (p = 0.076; analysis of variance) (C). Similarly, linear regression analysis revealed an 
inverse correlation between hcy levels and MTHFR promoter methylation (r = -0.15; p = 0.03) (D). 
These data can help the reader to understand some of the connections between variables revealed by 
Auto-CM analysis. 
 
 	  
